European Medical Journal news story
Acute hepatitis C is being diagnosed in a high-risk sexual health cohort in Madrid, with most cases occurring among MSM and a substantial proportion reporting chemsex and slamsex. The findings also highlight a low spontaneous clearance rate and ongoing gaps in linkage to care.
The study identified 92 cases of acute or recent hepatitis C virus (HCV) infection between January 2023 and January 2025. Nearly all cases (98.9%) occurred in MSM, with most patients either living with HIV (76.1%) or using HIV PrEP (20.7%).
Chemsex was reported by 78.3% of patients. In this study, chemsex refers to the intentional use of psychoactive substances in sexual contexts. Within this subgroup, 52.8% also reported slamsex, defined as injecting of drugs during sexual activity.
Of the 54 with additional available data, 17 had concurrent sexually transmitted infections, indicating overlapping sexual health risks in this cohort.
Read the full news story here.
Source : European Medical Journal
Related HIV and Co-Infections News
-
[Press release] AbbVie announces European Commission approval of MAVIRET® (glecaprevir/pibrentasvir) for people with acute hepatitis C virus infection
-
HIV i-Base: UKHSA continues to recommend 4CMenB vaccine against gonorrhoea in gay men
-
ECDC: Clusters of dermatophilosis in five EU/EEA countries in 2025–2026
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.